Skip to main content
. 2023 Jun 8;15(6):1677. doi: 10.3390/pharmaceutics15061677

Figure 3.

Figure 3

(A) (i) NNPs developed via physical extrusion for targeted drug delivery to pancreatic carcinoma. (ii) TEM image of NNPs. Scale bar: 30 nm. Reproduced from reference [127]. (B) DOX-loaded, macrophage cell membrane (MPCM)-camouflaged mesoporous silica nanocapsules (MSNCs) developed via physical extrusion method. Reproduced with permission from reference [129].